Advertisement

Selective Blockage by Islet-Activating Protein, Pertussis Toxin, of Negative Signal Transduction from Receptors to Adenylate Cyclase

  • Michio Ui
  • Toshiaki Katada
  • Toshihiko Murayama
  • Hitoshi Kurose
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 160)

Abstract

The adenylate cyclase-cyclic AMP system is one of the signal transduction processes that has been the subject of extensive studies in recent years. Stimulation of some membrane receptors (“activatory” receptors) by particular agonists produces, via activation of adenylate cyclase, cyclic AMP, which acts as an intracellular second messenger of the receptors by activating one of the several kinds of cytosolic protein kinases. The receptor-linked adenylate cyclase system is now known to consist of three components; the guanine nucleotide-binding protein usually referred to as N, G, or G/F, has been identified as the functional communicator between receptors (R) and the catalytic unit of the cyclase (C). A growing body of evidence has accumulated in support of the concept that N plays the pivotal role in receptor-mediated activation of adenylate cyclase, as reviewed by Ross and Gilman (1), Limbird (2) and Spiegel and Downs (3). When no extracellular signal is available to the cell, the species of the guanine nucleotide bound to N is GDP, which allows functional dissociation of the three components, R, N, and C. If information is transmitted by an agonist (A) which occupies R, the ternary complex, A-R-N is formed as the “turn-on” reaction which leads to replacement of GDP by intracellular GTP at the specific binding sites on N. The adenylate cyclase enzyme is then activated as a result of association of the GTP-bound N with C. Synthesis of cyclic AMP continues until GTP is hydrolyzed by the GTPase “turn-off” reaction, leaving GDP on N.

Keywords

Adenylate Cyclase Cholera Toxin Pertussis Toxin Adenylate Cyclase Activity Pertussis Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. M. Ross and A. G. Gilman, Biochemical properties of hormone-sensitive adenylate cyclase, Ann. Rev. Biochem. 49: 533 (1980).CrossRefGoogle Scholar
  2. 2.
    L. E. Limbird, Activation and attenuation of adenylate cyclase. The role of GTP-binding protein as macromolecular messengers in receptor-cyclase coupling, Biochem. J. 195: 1 (1981).Google Scholar
  3. 3.
    A. M. Spiegel and R. W. Downs, Guanine nucleotides: Key regulators of hormone receptor-adenylate cyclase interaction, Endocrine Rev. 2: 275 (1981).CrossRefGoogle Scholar
  4. 4.
    J. Moss and M. Vaughan, Activation of adenylate cyclase by choleragen, Ann. Rev. Biochem. 48: 581 (1979).CrossRefGoogle Scholar
  5. 5.
    K. H. Jacobs, Inhibition of adenylate cyclase by hormones and neurotransmitters, Mol. Cell. Endocrinol. 61: 147 (1979).CrossRefGoogle Scholar
  6. 6.
    M. Rodbell, The role of hormone receptors and GTP-regulatory proteins in membrane transduction, Nature 284: 17 (1980).CrossRefGoogle Scholar
  7. 7.
    D. M. F. Cooper, Bimodal regulation of adenylate cyclase, FEBS Lett. 138: 157 (1982).CrossRefGoogle Scholar
  8. 8.
    M. Yajima, K. Hosoda, Y. Kanbayashi, T. Nakamura, K. Nogimori, Y. Nakase, and M. Ui, Islet-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization, J. Biochem. 83: 295 (1978).Google Scholar
  9. 9.
    M. Yajima, K. Hosoda, Y. Kanbayashi, T. Nakamura, I. Takahashi, and M. Ui, Biological properties of islet-activating protein (IAP) purified from the culture medium of Bordetella pertussis, J. Biochem. 83: 305 (1978).Google Scholar
  10. 10.
    T. Katada and M. Ui, Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion, J. Biol. Chem. 255: 9580 (1980).Google Scholar
  11. 11.
    T. Katada and M. Ui, In vitro effects of islet-activating protein on cultured rat pancreatic islets. Enhancement of insulin secretion, cyclic AMP accumulation and Ca flux, J. Biochem. 89:979 (1981).Google Scholar
  12. 12.
    T. Katada and M. Ui, Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase, J. Biol. Chem. 256: 8310 (1981).Google Scholar
  13. 13.
    O. Hazeki and M. Ui, Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells, J. Biol. Chem. 256: 2856 (1981).Google Scholar
  14. 14.
    A. C. Wardlaw and R. Parton, Bordetella pertussis toxins, Pharmacol. Ther. 19: 1 (1983).CrossRefGoogle Scholar
  15. 15.
    H. Shikama and M. Ui, Metabolic background for glucose tolerance: mechanism for epinephrine-induced impairment, Am. J. Physiol. 229: 955 (1975).Google Scholar
  16. 16.
    H. Shikama and M. Ui, Adrenergic receptor and epinephrine-induced hyperglycemia and glucose tolerance, Am. J. Physiol. 229: 962 (1975).Google Scholar
  17. 17.
    M. Yajima and M. Ui, Carbohydrate metabolism and its response to catecholamines as modified in alkalotic rat, Am. J. Physiol. 228: 1046 (1975).Google Scholar
  18. 18.
    M. Yajima and M. Ui, Hypoglycemia induced by alpha-adrenergic stimulation during alkalosis, Europ. J. Pharmacol. 41: 93 (1977).CrossRefGoogle Scholar
  19. 19.
    M. Yajima and M. Ui, Hydrocortisone restoration of the pH-dependent metabolic responses to catecholamines, Am. J. Physiol. 228: 1053 (1975).Google Scholar
  20. 20.
    F. Okajima and M. Ui, Adrenergic modulation of insulin secretion in vivo dependent on thyroid states, Am. J. Physiol. 234: E106 (1978).Google Scholar
  21. 21.
    M. Yajima, T. Hosokawa, and M. Ui, An involvement of alphaadrenergic stimulation in exercise-induced hypoglycemia, Europ. J. Pharmacol. 42: 1 (1977).CrossRefGoogle Scholar
  22. 22.
    T. Sumi and M. Ui, Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats, Endocrinology 97: 352 (1975).CrossRefGoogle Scholar
  23. 23.
    T. Katada and M. Ui, Accelerated turnover of blood glucose in pertussis-sensitized rats due to combined actions of endogenous insulin and adrenergic beta-stimulation, Biochim. Biophys. Acta 421: 57 (1976).CrossRefGoogle Scholar
  24. 24.
    T. Katada and M. Ui, Perfusion of the pancreas isolated from pertussis-sensitized rats: potentiation of insulin secretory responses due to beta-adrenergic stimulation, Endocrinology 101: 1247 (1977).CrossRefGoogle Scholar
  25. 25.
    M. Ui, T. Katada, and M. Yajima, Islet-activating protein in Bordetella pertussis: Purification and mechanism of action, in: “International Symposium on Pertussis,” C. R. Manclark and J. C. Hills, eds., p. 166, DREW Publication No. (NIH)791830, Bethesda (1979).Google Scholar
  26. 26.
    M. Pittman, Pertussis toxin: The cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis, Rev. Infect. Dis. 1: 401 (1979).CrossRefGoogle Scholar
  27. 27.
    J. J. Munoz and R. K. Bergman, Biological activity of Bordetella pertussis, in: “International Symposium on Pertussis,” C. R. Manclark and J. C. Hills, eds., p. 143, DREW Publication No. (NIH) 79–1830, Bethesda (1979).Google Scholar
  28. 28.
    M. Ui and T. Katada, A novel action of the islet-activating protein (IAP) to modify adrenergic regulation of insulin secretion, in: “Proinsulin, Insulin and C-Peptide,” S. Baba, T. Kaneko, and N. Yanaibara, eds., p. 124, Excerpta Medica, Amsterdam-Oxford (1979).Google Scholar
  29. 29.
    T. Katada and M. Ui, Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores, J. Biol. Chem. 254: 469 (1979).Google Scholar
  30. 30.
    T. Katada and M. Ui, Effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium, Endocrinology 104: 1822 (1979).CrossRefGoogle Scholar
  31. 31.
    S. Yamazaki, T. Katada, and M. Ui, Alpha(2)-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets, Mol. Pharmacol. 21: 648 (1982).Google Scholar
  32. 32.
    O. Hazeki, T. Katada, H. Kurose, and M. Ui, Effect of adenosine on cyclic AMP accumulation in cardiac and other cells and its modification by islet-activating protein, in: “Physiology and Pharmacology of Adenosine Derivatives,” J. W. Daly, Y. Kuroda, J. W. Phillis, H. Shimizu, and M. Ui, eds., p. 41, Raven Press, New York (1983).Google Scholar
  33. 33.
    T. Murayama and M. Ui, Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP-ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes, J. Biol. Chem. 258: 3319 (1983).Google Scholar
  34. 34.
    T. Katada, T. Amano, and M. Ui, Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells, J. Biol. Chem. 257: 3739 (1982).Google Scholar
  35. 35.
    T. Murayama, T. Katada, and M. Ui, Guanine nucleotide activation and inhibition of adenylate cyclase as modified by islet-activating protein, pertussis toxin, in mouse 3T3 fibroblasts, Arch. Biochem. Biophys. 221: 381 (1983).CrossRefGoogle Scholar
  36. 36.
    H. Kurose, T. Katada, T. Amano, and M. Ui, Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells, J. Biol. Chem. 258: 4870 (1983).Google Scholar
  37. 37.
    H. Kurose and M. Ui, Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin, submitted.Google Scholar
  38. 38.
    T. Katada and M. Ui, Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein, Proc. Natl. Acad. Sci. USA 79: 3129 (1982).CrossRefGoogle Scholar
  39. 39.
    T. Katada and M. Ui, ADP-ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity, J. Biol. Chem. 257: 7210 (1982).Google Scholar
  40. 40.
    M. Ui, T. Katada, T. Murayama, H. Kurose, M. Yajima, M. Tamura, T. Nakamura, and K. Nogimori, Islet-activating protein, pertussis toxin: a specific uncoupler of receptor-mediated inhibition of adenylate cyclase, in: “Advances in Cyclic Nucleotide Research,” vol. 16, P. Greengard, G. A. Robison, and R. Paoletti, eds., Raven Press, New York, (1984).Google Scholar
  41. 41.
    D. L. Burns, E. L. Hewlett, J. Moss, and M. Vaughan, Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108–15 cells, J. Biol. Chem. 258: 1435 (1983).Google Scholar
  42. 42.
    T. Murayama and M. Ui, GDP release from rat and hamster adipocyte membranes independently linked to receptors involved in activation or inhibition of adenylate cyclase. Differential susceptibility to two bacterial toxins, J. Biol. Chem. 259: in press.Google Scholar
  43. 43.
    T. Nakamura and M. Ui, Suppression of passive cutaneous anaphylaxis by pertussis toxin, an islet-activating protein, as a result of inhibition of histamine release from mast cells, Biochem. Pharmacol. 32: in press.Google Scholar
  44. 44.
    T. Nakamura and M. Ui, Mast cell phospholipase inhibition by islet-activating protein, pertussis toxin, as associated with suppressed histamine release, submitted.Google Scholar
  45. 45.
    M. Tamura, K. Nogimori, S. Murai, M. Yajima, K. Ito, T. Katada, M. Ui, and S. Ishii, Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model, Biochemistry 21: 5516 (1982).CrossRefGoogle Scholar
  46. 46.
    T. Katada, M. Tamura, and M. Ui, The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein, Arch. Biochem. Biophys. 224: 290 (1983).CrossRefGoogle Scholar
  47. 47.
    M. Tamura, K. Nogimori, Y. Yajima, K. Ase, and M. Ui, A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells, J. Biol. Chem. 258: 6756 (1983).Google Scholar
  48. 48.
    D. M. Gill, Seven toxin peptides that cross cell membranes, in: “Bacterial Toxins and Cell Membranes,” J. Jeljaszewicz, and T. Wadstrom, eds., p. 291, Academic Press, New York (1978).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Michio Ui
    • 1
  • Toshiaki Katada
    • 1
  • Toshihiko Murayama
    • 1
  • Hitoshi Kurose
    • 1
  1. 1.Department of Physiological Chemistry Faculty of Pharmaceutical SciencesHokkaido UniversitySapporo 060Japan

Personalised recommendations